Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GILBERT J KUHN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1144317629
CMS profile
51885
Location
SANTA MONICA, CA

General Payments · PY2018–2024

$10,131.11

  • Reported across 202 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$318.71

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $318.71 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $146.10 6
Lilly USA, LLC $89.75 4
Acerta Pharma LLC $59.69 3
E.R. Squibb & Sons, L.L.C. $23.17 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,338.87 68
PY2019 $1,050.05 55
PY2020 $389.29 17
PY2021 $258.93 13
PY2022 $446.34 21
PY2023 $328.92 14
PY2024 $318.71 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $17.71 02/23/2024 Food and Beverage Undisputed 01/23/2026 1104624792 CMS
AstraZeneca Pharmaceuticals LP $27.04 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105638436 CMS
AstraZeneca Pharmaceuticals LP $14.94 11/25/2024 Food and Beverage Undisputed 01/23/2026 1104416587 CMS
E.R. Squibb & Sons, L.L.C. $23.17 12/04/2024 Food and Beverage Undisputed 01/23/2026 1101348762 CMS
GlaxoSmithKline, LLC. $25.44 02/07/2024 Food and Beverage Undisputed 01/23/2026 1115845633 CMS
GlaxoSmithKline, LLC. $24.23 03/28/2024 Food and Beverage Undisputed 01/23/2026 1116078026 CMS
GlaxoSmithKline, LLC. $26.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 1116624263 CMS
GlaxoSmithKline, LLC. $20.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116394620 CMS
GlaxoSmithKline, LLC. $25.22 08/22/2024 Food and Beverage Undisputed 01/23/2026 1116241091 CMS
GlaxoSmithKline, LLC. $23.59 10/17/2024 Food and Beverage Undisputed 01/23/2026 1116652285 CMS
Lilly USA, LLC $27.38 01/18/2024 Food and Beverage Undisputed 01/23/2026 1134987802 CMS
Lilly USA, LLC $19.40 03/13/2024 Food and Beverage Undisputed 01/23/2026 1134987456 CMS
Lilly USA, LLC $22.56 07/17/2024 Food and Beverage Undisputed 01/23/2026 1135002416 CMS
Lilly USA, LLC $20.41 09/19/2024 Food and Beverage Undisputed 01/23/2026 1134988130 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.